Corcept Therapeutics Incorporated (CORT) Institutional Ownership

Based on Q1 2026 13F filings, institutional ownership of Corcept Therapeutics Incorporated stands at 32.6%, held across 343 reporting institutions.

BlackRock, Inc. is the largest reported institutional holder of CORT, with approximately 12,151,276 shares worth $0.49B as of Q1 2026.

Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of CORT, including RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP.

Our composite Smart Money Score for CORT is 60 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

75 institutions opened new positions in CORT during Q1 2026, while 113 fully exited. 191 added to existing positions and 76 trimmed.

CORT institutional ownership rose by 4.99 percentage points quarter-over-quarter, with a net change of -38 holders.

The top 10 institutions account for 60.5% of all reported 13F value in CORT, and the top 25 account for 80.6%.

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.